S. Batzios, D. Zafeiriou, and E. Papakonstantinou, Extracellular matrix components: An intricate network of possible biomarkers for lysosomal storage disorders?, FEBS Lett, vol.587, pp.1258-1267, 2013.

A. M. Montaño, Clinical course of sly syndrome (mucopolysaccharidosis type VII), J. Med. Genet, 2016.

S. Tomatsu, Molecular basis of mucopolysaccharidosis type VII: replacement of Ala619 in ?-glucuronidase with Val, Gene, vol.89, pp.283-287, 1990.

S. Tomatsu, A. M. Montaño, V. C. Dung, J. H. Grubb, and W. S. Sly, Mutations and Polymorphisms in GUSB Gene in Mucopolysaccharidosis VII (Sly Syndrome), Hum Mutat, vol.30, pp.511-519, 2009.

P. Wang, Mucopolysaccharidosis VII in a Cat Caused by 2 Adjacent Missense Mutations in the GUSB Gene, J Vet Intern Med, vol.29, pp.1022-1028, 2015.

G. Lee and L. Studer, Induced pluripotent stem cell technology for the study of human disease, Nat Methods, vol.7, pp.25-27, 2010.

K. Takahashi, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, vol.131, pp.861-72, 2007.

D. K. Borger, Induced pluripotent stem cell models of lysosomal storage disorders, Dis. Model. Mech, vol.10, pp.691-704, 2017.

G. Tiscornia, Neuronopathic Gaucher's disease: induced pluripotent stem cells for disease modelling and testing chaperone activity of small compounds, Hum Mol Genet, vol.22, pp.633-645, 2013.

J. Tolar, Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome), Blood, vol.117, pp.839-847, 2011.

T. Higuchi, S. Kawagoe, M. Otsu, Y. Shimada, and H. Kobayashi, The generation of induced pluripotent stem cells (iPSCs) from patients with infantile and late-onset types of Pompe disease and the effects of treatment with acid-? -glucosidase in Pompe iPSCs, Mol. Genet. Metab, vol.112, pp.44-48, 2014.

T. Lemonnier, Modeling neuronal defects associated with a lysosomal disorder using patient-derived induced pluripotent stem cells, Hum. Mol. Genet, vol.20, pp.3653-3666, 2011.

I. Canals, Activity and high-order effective connectivity alterations in sanfilippo C patient-specific neuronal networks, Stem Cell Reports, vol.5, pp.546-557, 2015.

D. Maetzel, Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick Type C patient-specific iPS cells, Stem Cell Reports, vol.2, pp.866-880, 2014.

T. A. Griffin, H. C. Anderson, and J. H. Wolfe, Ex vivo gene therapy using patient iPSC-derived NSCs reverses pathology in the brain of a homologous mouse model, Stem Cell Reports, vol.4, pp.835-846, 2015.

V. Meneghini, Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy, Stem Cells Transl. Med, vol.6, pp.352-368, 2017.

J. Doerr, A overexpressing human iPSC-derived neural cells reduce CNS sulfatide storage in a mouse model of metachromatic leukodystrophy, Mol. Ther, vol.23, pp.1519-1531, 2015.

P. Srikanth and T. L. Young-pearse, Stem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells, J. Neurogenet, vol.28, pp.5-29, 2014.

D. Simão, Recapitulation of human neural microenvironment signatures in iPSC-derived NPC 3D differentiation, Stem Cell Reports, 2018.

D. Simão, Perfusion Stirred-Tank Bioreactors for 3D Differentiation of Human Neural Stem Cells, Methods Mol. Biol, 2016.

A. Chabas, M. Giros, and A. Guardiola, Low beta-glucuronidase activity in a healthy member of a family with mucopolysaccharidosis VII, J Inherit Metab Dis, vol.14, pp.908-914, 1991.

S. M. Chambers, Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling, Nat Biotechnol, vol.27, pp.275-280, 2009.

C. M. Simonaro, Involvement of the Toll-like receptor 4 pathway and use of TNF-alpha antagonists for treatment of the mucopolysaccharidoses, Proc. Natl. Acad. Sci. USA, vol.107, pp.222-229, 2010.

L. Ariza, Central Nervous System Delivery of Helper-Dependent Canine Adenovirus Corrects Neuropathology and Behavior in Mucopolysaccharidosis Type VII Mice, Hum. Gene Ther, vol.25, pp.199-201, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02191549

B. A. Karolewski and J. H. Wolfe, Genetic correction of the fetal brain increases the lifespan of mice with the severe multisystemic disease mucopolysaccharidosis type VII, Mol. Ther, vol.14, pp.14-24, 2006.

A. Cubizolle, Corrective GUSB transfer to the canine mucopolysaccharidosis VII brain, Mol. Ther, vol.181, pp.22-31, 2013.
URL : https://hal.archives-ouvertes.fr/hal-02192868

M. Sardiello, A gene network regulating lysosomal biogenesis and function, Science, vol.325, pp.473-477, 2009.

F. Loustalot, E. J. Kremer, and S. Salinas, International Review of Cell and Molecular Biology, vol.322, pp.331-362, 2016.

E. Seiradake, H. Lortat-jacob, O. Billet, E. Kremer, and S. Cusack, Structural and mutational analysis of human Ad37 and canine adenovirus 2 fiber heads in complex with the D1 domain of coxsackie and adenovirus receptor, J Biol Chem, vol.281, 2006.
URL : https://hal.archives-ouvertes.fr/hal-01062657

S. Salinas, Disruption of the coxsackievirus and adenovirus receptor-homodimeric interaction triggers lipid microdomain-and dynamin-dependent endocytosis and lysosomal targeting, J Biol Chem, vol.289, pp.680-695, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02193683

T. Patel, K. Man, B. Firestein, and D. Meaney, Automated quantification of neuronal networks and single-cell calcium dynamics using calcium imaging, J. Neurosci, vol.243, pp.26-38, 2015.

K. Tanabe, Transdifferentiation of human adult peripheral blood T cells into neurons, Proc. Natl. Acad. Sci, vol.115, pp.6470-6475, 2018.

J. W. B?aszczyk, Parkinson's disease and neurodegeneration: GABA-collapse hypothesis, Front. Neurosci, vol.10, 2016.

S. U. Walkley, H. J. Baker, M. C. Rattazzi, M. E. Haskins, and J. Y. Wu, Neuroaxonal dystrophy in neuronal storage disorders: Evidence for major GABAergic neuron involvement, J. Neurol. Sci, vol.104, pp.1-8, 1991.

S. U. Walkley, Cellular pathology of lysosomal storage disorders, Brain Pathol, vol.8, pp.175-193, 1998.

M. K. Parente, R. Rozen, C. N. Cearley, and J. H. Wolfe, Dysregulation of gene expression in a lysosomal storage disease varies between brain regions implicating unexpected mechanisms of neuropathology, PLoS One, vol.7, 2012.

K. Hamano, M. Hayashi, K. Shioda, R. Fukatsu, and S. Mizutani, Mechanisms of neurodegeneration in mucopolysaccharidoses II and IIIB: Analysis of human brain tissue, Acta Neuropathol, vol.115, pp.547-559, 2008.

H. Phatnani and T. Maniatis, Astrocytes in Neurodegenerative Disease, Cold Spring Harb. Perspect. Biol, vol.7, p.20628, 2015.

M. Sofroniew and H. V. Vinters, Astrocytes: biology and pathology. 7-35, 2010.

M. K. Parente, R. Rozen, S. H. Seeholzer, and J. Wolfe, Integrated analysis of proteome and transcriptome changes in the mucopolysaccharidosis type VII mouse hippocampus, Mol. Genet. Metab, vol.118, pp.41-54, 2016.

L. Ben-haim, M. Carrillo-de-sauvage, K. Ceyzériat, and C. Escartin, Elusive roles for reactive astrocytes in neurodegenerative diseases, Front. Cell. Neurosci, vol.9, p.278, 2015.
URL : https://hal.archives-ouvertes.fr/cea-02142599

M. E. Bosch and T. Kielian, Neuroinflammatory paradigms in lysosomal storage diseases, Front. Neurosci, vol.9, pp.1-11, 2015.

L. D. Archer, K. J. Langford-smith, B. W. Bigger, and J. E. Fildes, Mucopolysaccharide diseases: A complex interplay between neuroinflammation, microglial activation and adaptive immunity, J. Inherit. Metab. Dis, vol.37, pp.1-12, 2014.

K. V. Rao and T. Kielian, Astrocytes and Lysosomal Storage Diseases, Neuroscience, vol.323, pp.195-206, 2016.

A. Ballabio and V. Gieselmann, Lysosomal disorders: from storage to cellular damage, Biochim. Biophys. Acta, vol.1793, pp.684-696, 2009.

E. M. Xing, S. Wu, and K. P. Ponder, The effect of Tlr4 and/or C3 deficiency and of neonatal gene therapy on skeletal disease in mucopolysaccharidosis VII mice, Mol. Genet. Metab, vol.114, pp.209-216, 2015.

J. Ausseil, Early neurodegeneration progresses independently of microglial activation by heparan sulfate in the brain of mucopolysaccharidosis IIIB mice, PLoS One, vol.3, p.2296, 2008.

J. Metcalf, Y. Zhang, M. Hilton, F. Long, and K. Ponder, Mechanism of shortened bones in mucopolysaccharidosis VII, Mol Genet Metab, vol.97, pp.202-211, 2009.

D. Malta, C. Fryer, J. Settembre, C. Ballabio, and A. , Autophagy in astrocytes: a novel culprit in lysosomal storage disorders, Autophagy, vol.8, pp.1871-1872, 2012.

J. P. Luzio, Y. Hackmann, N. M. Dieckmann, and G. M. Griffiths, The biogenesis of lysosomes and lysosome-related organelles, Cold Spring Harb. Perspect. Biol, vol.6, pp.1-18, 2014.

S. M. Ferguson, Axonal transport and maturation of lysosomes, Curr. Opin. Neurobiol, vol.51, pp.45-51, 2018.

K. Suzuki and R. Terry, Fine structural localization of acid phosphatase in senile plaques in Alzheimer's presenile dementia, Acta Neuropathol, vol.8, pp.276-284, 1967.

M. Beck, The Link Between Lysosomal Storage Disorders and More CommonDiseases, J. Inborn Errors Metab. Screen, vol.4, p.232640981668276, 2016.

S. Morita, T. Kojima, and T. Kitamura, Plat-E: an efficient and stable system for transient packaging of retroviruses, Gene Ther, vol.7, pp.1063-1066, 2000.

P. E. Mangeot, Protein transfer into human cells by VSV-G-induced nanovesicles, Mol. Ther, vol.19, pp.1656-1666, 2011.

D. Huangfu, Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds, Nat. Biotechnol, vol.26, pp.795-797, 2008.

N. Cereso, Proof of concept for AAV2/5-mediated gene therapy in iPSC-derived retinal pigment epithelium of a choroideremia patient, Mol. Ther. -Methods Clin. Dev, vol.1, p.14011, 2014.

F. Zhu, A modified method for implantation of pluripotent stem cells under the rodent kidney capsule, Stem Cells Dev, vol.23, pp.2119-2144, 2014.

T. A. Prokhorova, Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel, Stem Cells Dev, vol.18, pp.47-54, 2009.

S. E. Peterson, Teratoma Generation in the Testis Capsule, J. Vis. Exp, vol.9, pp.9-11, 2011.

F. J. Müller, J. Goldmann, P. Löser, and J. F. Loring, A call to standardize teratoma assays used to define human pluripotent cell lines, Cell Stem Cell, vol.6, pp.412-414, 2010.

S. M. Chambers, Y. Mica, G. Lee, L. Studer, and M. J. Tomishima, Dual-SMAD Inhibition/WNT Activation-Based Methods to Induce Neural Crest and Derivatives from Human Pluripotent Stem Cells, Methods Mol. Biol, vol.1307, pp.329-343, 2015.

N. Gaspard, Generation of cortical neurons from mouse embryonic stem cells, Nat. Protoc, vol.4, pp.1454-1463, 2009.

E. B. Vitner, F. M. Platt, and A. H. Futerman, Common and uncommon pathogenic cascades in lysosomal storage diseases, J Biol Chem, vol.285, pp.20423-20427, 2010.

J. Schindelin, Fiji: an open-source platform for biological-image analysis, Nat. Methods, vol.9, pp.676-682, 2012.

G. W. Zack and E. Rogers, Automatic Measurement of Sister Chromatid Exchange Frequency, J. Histochem. Cytochem, vol.25, pp.741-753, 1977.

C. Brito, 3D cultures of human neural progenitor cells: dopaminergic differentiation and genetic modification, Methods, vol.56, pp.452-60, 2012.

K. J. Livak and T. D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods, vol.25, pp.402-410, 2001.

M. &. Gaffield and W. J. Betz, Imaging synaptic vesicle exocytosis and endocytosis with FM dyes, Nat. Protoc, vol.1, pp.2916-2937, 2006.

R. Mri, R. Chromostem, ). , and B. , This study was funded in part by the European commission (FP7 BrainCAV 222992 (EJK), Government of Catalonia (with the support of the Secretary for Universities and Research of the Ministry of Economy and Knowledge of the Government of Catalonia and the COFUND program of the Marie Curie Actions of the 7th R&D Framework Program of the European Union) (NBP), IGMM (EJK), LabEx EpiGenMed, an "Investissements d'avenir" program, La Fondation pour la Recherche Médicale (EJK), E-Rare (AB, EJK), Vaincre les Maladies Lysosomales (NBP, EJK)

P. Fct, European Research Council (2012-StG-311736-PD-HUMMODEL (AC)), the Spanish Ministry of Economy and Competitiveness-MINECO (BFU2016-80870-P (AC)